Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention

Abstract Myocardial fibrosis and ventricular remodeling were the key pathology factors causing undesirable consequence after myocardial infarction. However, an efficient therapeutic method remains unclear, partly due to difficulty in continuously preventing neurohormonal overactivation and potential...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zeping Qiu, Jingwen Zhao, Fanyi Huang, Luhan Bao, Yanjia Chen, Ke Yang, Wenguo Cui, Wei Jin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Acceso en línea:https://doaj.org/article/e774ffa4f866423787236636797b8e4a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e774ffa4f866423787236636797b8e4a
record_format dspace
spelling oai:doaj.org-article:e774ffa4f866423787236636797b8e4a2021-12-02T16:27:51ZMyocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention10.1038/s41536-021-00154-y2057-3995https://doaj.org/article/e774ffa4f866423787236636797b8e4a2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41536-021-00154-yhttps://doaj.org/toc/2057-3995Abstract Myocardial fibrosis and ventricular remodeling were the key pathology factors causing undesirable consequence after myocardial infarction. However, an efficient therapeutic method remains unclear, partly due to difficulty in continuously preventing neurohormonal overactivation and potential disadvantages of cell therapy for clinical practice. In this study, a rhACE2-electrospun fibrous patch with sustained releasing of rhACE2 to shape an induction transformation niche in situ was introduced, through micro-sol electrospinning technologies. A durable releasing pattern of rhACE2 encapsulated in hyaluronic acid (HA)—poly(L-lactic acid) (PLLA) core-shell structure was observed. By multiple in vitro studies, the rhACE2 patch demonstrated effectiveness in reducing cardiomyocytes apoptosis under hypoxia stress and inhibiting cardiac fibroblasts proliferation, which gave evidence for its in vivo efficacy. For striking mice myocardial infarction experiments, a successful prevention of adverse ventricular remodeling has been demonstrated, reflecting by improved ejection fraction, normal ventricle structure and less fibrosis. The rhACE2 patch niche showed clear superiority in long term function and structure preservation after ischemia compared with intramyocardial injection. Thus, the micro-sol electrospun rhACE2 fibrous patch niche was proved to be efficient, cost-effective and easy-to-use in preventing ventricular adverse remodeling.Zeping QiuJingwen ZhaoFanyi HuangLuhan BaoYanjia ChenKe YangWenguo CuiWei JinNature PortfolioarticleMedicineRENnpj Regenerative Medicine, Vol 6, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
spellingShingle Medicine
R
Zeping Qiu
Jingwen Zhao
Fanyi Huang
Luhan Bao
Yanjia Chen
Ke Yang
Wenguo Cui
Wei Jin
Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
description Abstract Myocardial fibrosis and ventricular remodeling were the key pathology factors causing undesirable consequence after myocardial infarction. However, an efficient therapeutic method remains unclear, partly due to difficulty in continuously preventing neurohormonal overactivation and potential disadvantages of cell therapy for clinical practice. In this study, a rhACE2-electrospun fibrous patch with sustained releasing of rhACE2 to shape an induction transformation niche in situ was introduced, through micro-sol electrospinning technologies. A durable releasing pattern of rhACE2 encapsulated in hyaluronic acid (HA)—poly(L-lactic acid) (PLLA) core-shell structure was observed. By multiple in vitro studies, the rhACE2 patch demonstrated effectiveness in reducing cardiomyocytes apoptosis under hypoxia stress and inhibiting cardiac fibroblasts proliferation, which gave evidence for its in vivo efficacy. For striking mice myocardial infarction experiments, a successful prevention of adverse ventricular remodeling has been demonstrated, reflecting by improved ejection fraction, normal ventricle structure and less fibrosis. The rhACE2 patch niche showed clear superiority in long term function and structure preservation after ischemia compared with intramyocardial injection. Thus, the micro-sol electrospun rhACE2 fibrous patch niche was proved to be efficient, cost-effective and easy-to-use in preventing ventricular adverse remodeling.
format article
author Zeping Qiu
Jingwen Zhao
Fanyi Huang
Luhan Bao
Yanjia Chen
Ke Yang
Wenguo Cui
Wei Jin
author_facet Zeping Qiu
Jingwen Zhao
Fanyi Huang
Luhan Bao
Yanjia Chen
Ke Yang
Wenguo Cui
Wei Jin
author_sort Zeping Qiu
title Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
title_short Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
title_full Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
title_fullStr Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
title_full_unstemmed Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
title_sort myocardial fibrosis reversion via rhace2-electrospun fibrous patch for ventricular remodeling prevention
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e774ffa4f866423787236636797b8e4a
work_keys_str_mv AT zepingqiu myocardialfibrosisreversionviarhace2electrospunfibrouspatchforventricularremodelingprevention
AT jingwenzhao myocardialfibrosisreversionviarhace2electrospunfibrouspatchforventricularremodelingprevention
AT fanyihuang myocardialfibrosisreversionviarhace2electrospunfibrouspatchforventricularremodelingprevention
AT luhanbao myocardialfibrosisreversionviarhace2electrospunfibrouspatchforventricularremodelingprevention
AT yanjiachen myocardialfibrosisreversionviarhace2electrospunfibrouspatchforventricularremodelingprevention
AT keyang myocardialfibrosisreversionviarhace2electrospunfibrouspatchforventricularremodelingprevention
AT wenguocui myocardialfibrosisreversionviarhace2electrospunfibrouspatchforventricularremodelingprevention
AT weijin myocardialfibrosisreversionviarhace2electrospunfibrouspatchforventricularremodelingprevention
_version_ 1718384024636882944